A Phase 4, Single-arm, Open-label Study to Evaluate the Effectiveness and Safety of Tezepelumab in Patients With Severe Asthma, Including Underrepresented Racial and Clinical Groups: Initial Baseline Demographics and Clinical Characteristics From the PASSAGE Study

N.L. Lugogo, K. Sumino,P. Akuthota, A.F. Burnette, S.K. Mathur,A.W. Lindsley,J.-P. Llanos, C. Marchese,B. Cook, N. Martin,C.S. Ambrose, B. Emmanuel

C34. BIOLOGIC THERAPY IN THE FIGHT AGAINST ASTHMA AND ALLERGIC INFLAMMATION（2024）

引用 0|浏览2

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要